Join us in Philadelphia from Sept. 25-27th for our "Together We Will" Weekend: - Register today!

The Desmoid Tumor Research Foundation

March 2025

Secondary osteosarcoma after carbon-ion radiotherapy for desmoid-type fibromatosis: A case report

Author Information

Mizuki Aketo 1, Makoto Emori 1, Kohichi Takada 2, Kazuyuki Murase 2, Yohei Arihara 2, Junya Shimizu 1, Yasutaka Murahashi 1, Masahiko Okamoto 3 4, Shintaro Sugita 5, Atsushi Teramoto 1

1Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine, Sapporo, Japan.2Department of Medical Oncology, Sapporo Medical University School of Medicine, Sapporo, Japan.3Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan.4Gunma University Heavy Ion Medical Center, Maebashi, Japan.5Department of Surgical Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan.

Publication

Cancer Rep.

Summary

BACKGROUND: Radiotherapy is considered an alternative treatment for unresectable or pharmacologically resistant desmoid-type fibromatosis. While it results in relatively good local control, the risk of secondary malignancy remains a concern. CASE: We present a case of secondary osteosarcoma after carbon-ion radiation therapy (CIRT). A 31-year-old male patient presented with left thigh pain. The tumor was located between the left gluteus maximus and gluteus medius and extended to the vastus lateralis and biceps femoris. It was diagnosed as desmoid-type fibromatosis after needle biopsy. The patient was treated with several medications, including a cyclooxygenase 2 inhibitor and tamoxifen; however, his left thigh pain did not improve. He was treated with CIRT 1 year after diagnosis (67.2 Gy [relative biological effectiveness] 16fr/4wks). He developed osteosarcoma of the left femur 8 years later. He underwent chemotherapy and tumor excision with disarticulation of the left hip. Pulmonary metastasis was detected 6 and 17 months after the definitive surgery and excised using metastasectomy. However, he died due to the recurrence of multiple pulmonary metastases 29 months after the definitive surgery. CONCLUSIONS: In this case, we believe that the low radiation dose to the femur may have caused secondary malignancy.

View Abstract